FLT1 and colorectal cancer: Low VEGFR-1 gene expression levels in metastatic colorectal cancer were predictive of prolonged OS after antiangiogenic therapy [44] and a high percentage of VEGFR-1+ cells in liver metastasis from colorectal cancer have been associated with worse patient outcomes [22].